Publications by authors named "Naiying Lan"
Background: Protein Energy Wasting (PEW) has high incidence in adult hemodialysis patients and refers to a state of decreased protein and energy substance. It has been demonstrated that PEW highly affects the quality of survival and increases the risk of death. Nevertheless, its diagnostic criteria are complex in clinic.
View Article and Find Full Text PDFArticle Synopsis
- Tislelizumab, an anti-PD-1 antibody approved in China and Europe, generally shows a good safety profile with no severe liver or kidney issues reported.
- A case study of a 74-year-old man revealed he experienced significant acute kidney (grade 3) and liver (grade 4) injuries after receiving tislelizumab for esophageal cancer, confirming previously known risks of immune checkpoint inhibitors (ICIs).
- The case underscores the necessity for careful monitoring and management of ICI-related toxicities and emphasizes the need for more research to understand risk factors and develop effective treatments.